Lorem ipsum dolor sit amet, consectetur adipiscing elit ut aliquam

value award of MedTech

CardiaCare has been selected as one of the top five companies in the value award of MedTech Innovator 2022 cohort

CardiaCare Completes Successful First In Human Clinical Trial of Home-Care treatment for Atrial Fibrillation

CardiaCare successfully completed it’s First in Human Clinical trial in Atrial Fibrillation (AF) patients arriving to the emergency room of the Chaim Sheba Medical Center. Patients have received the CardiaCare RR2 device for 8 weeks of home-care neuromodulation therapy and monitoring. The results demonstrated a high device safety profile, a significant acute reduction in AF precursor arrythmia events as well as long term reduction in AF recurrence rates after discharge from the hospital. In this real-life population study the home-care compliance with with device monitoring and therapeutic capabilities was extremely high.

CardiaCare Awarded First Prize at ICI2019 Startup Competition

TEL AVIV, Israel, Dec. 16, 2019 /PRNewswire/ — CardiaCare, a startup developing wearable therapeutic devices for treating and monitoring AFib, announced today that it has been named the First Prize winner of the 2019 Innovation in Cardiovascular Interventions (ICI) Technology Parade in Tel Aviv. CardiaCare presented its innovative product, a wearable neuromodulation (nerve stimulation) device for monitoring and treating AFIb. Read More.


Lorem ipsum dolor sit amet, consectetur
adipiscing elit ut aliquam, purus sit amet luctus

CardiaCare presenting

CardiaCare presenting at 16th International Dead Sea Symposium on Innovations in Cardiac Arrhythmias and Heart Failure (IDSS) 2020.

Our Prizes

Prize 1

CardiaCare Awarded First Prize Winner of the Technology Parade Startup Competition in ICI2019 Meeting


השאירו פרטים לבדיקת התאמתכם להשתתפות במחקר

Contact Us

Leave your message